InfuSystem Holdings, Inc. (INFU)
USD 8.26
(-8.93%)
USD 8.26
(-8.93%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 59.02 Million USD | -6.54% |
| 2022 | 60.91 Million USD | 6.17% |
| 2021 | 57.37 Million USD | 14.91% |
| 2020 | 49.93 Million USD | 15.16% |
| 2019 | 43.35 Million USD | 12.32% |
| 2018 | 38.6 Million USD | -16.41% |
| 2017 | 46.18 Million USD | 5.52% |
| 2016 | 43.76 Million USD | 3.42% |
| 2015 | 42.32 Million USD | 11.3% |
| 2014 | 38.02 Million USD | 0.64% |
| 2013 | 37.78 Million USD | -7.65% |
| 2012 | 40.91 Million USD | 19.91% |
| 2011 | 34.11 Million USD | -1.06% |
| 2010 | 34.48 Million USD | 47.94% |
| 2009 | 23.3 Million USD | 8.73% |
| 2008 | 21.43 Million USD | 231.91% |
| 2007 | 6.45 Million USD | -68.98% |
| 2006 | 20.82 Million USD | 84955.53% |
| 2005 | 24.48 Thousand USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 14.26 Million USD | -14.94% |
| 2024 Q1 | 16.77 Million USD | 16.35% |
| 2023 Q2 | 15.19 Million USD | -2.9% |
| 2023 FY | 56.93 Million USD | -6.54% |
| 2023 Q4 | 14.41 Million USD | -0.93% |
| 2023 Q1 | 15.64 Million USD | 3.93% |
| 2023 Q3 | 14.54 Million USD | -4.25% |
| 2022 Q3 | 15.27 Million USD | 3.96% |
| 2022 Q1 | 15.89 Million USD | 15.91% |
| 2022 FY | 60.91 Million USD | 6.17% |
| 2022 Q4 | 15.05 Million USD | -1.45% |
| 2022 Q2 | 14.69 Million USD | -7.54% |
| 2021 Q2 | 14.35 Million USD | 4.75% |
| 2021 Q4 | 13.71 Million USD | -12.16% |
| 2021 FY | 57.37 Million USD | 14.91% |
| 2021 Q1 | 13.7 Million USD | -1.85% |
| 2021 Q3 | 15.6 Million USD | 8.74% |
| 2020 Q1 | 12.63 Million USD | 8.54% |
| 2020 FY | 49.93 Million USD | 15.16% |
| 2020 Q4 | 13.96 Million USD | 17.63% |
| 2020 Q3 | 11.86 Million USD | 3.46% |
| 2020 Q2 | 11.47 Million USD | -9.17% |
| 2019 Q4 | 11.63 Million USD | 10.03% |
| 2019 FY | 43.35 Million USD | 12.32% |
| 2019 Q1 | 10.76 Million USD | 10.73% |
| 2019 Q2 | 10.38 Million USD | -3.49% |
| 2019 Q3 | 10.57 Million USD | 1.83% |
| 2018 FY | 38.6 Million USD | -16.41% |
| 2018 Q3 | 9.64 Million USD | -1.17% |
| 2018 Q2 | 9.75 Million USD | 2.87% |
| 2018 Q1 | 9.48 Million USD | -18.57% |
| 2018 Q4 | 9.71 Million USD | 0.78% |
| 2017 Q4 | 11.64 Million USD | 11.13% |
| 2017 Q2 | 11.43 Million USD | -9.39% |
| 2017 FY | 46.18 Million USD | 5.52% |
| 2017 Q1 | 12.61 Million USD | 13.62% |
| 2017 Q3 | 10.48 Million USD | -8.33% |
| 2016 FY | 43.76 Million USD | 3.42% |
| 2016 Q4 | 11.1 Million USD | 13.17% |
| 2016 Q1 | 12.14 Million USD | 13.5% |
| 2016 Q2 | 10.7 Million USD | -11.84% |
| 2016 Q3 | 9.81 Million USD | -8.33% |
| 2015 Q1 | 10.53 Million USD | 19.05% |
| 2015 FY | 42.32 Million USD | 11.3% |
| 2015 Q4 | 10.69 Million USD | 1.44% |
| 2015 Q3 | 10.54 Million USD | 0.09% |
| 2015 Q2 | 10.53 Million USD | 0.0% |
| 2014 Q2 | 9.58 Million USD | -6.94% |
| 2014 FY | 38.02 Million USD | 0.64% |
| 2014 Q4 | 8.85 Million USD | -4.69% |
| 2014 Q3 | 9.28 Million USD | -3.11% |
| 2014 Q1 | 10.3 Million USD | 12.86% |
| 2013 Q1 | 9.77 Million USD | -6.42% |
| 2013 Q2 | 9.46 Million USD | -3.09% |
| 2013 Q3 | 9.41 Million USD | -0.55% |
| 2013 FY | 37.78 Million USD | -7.65% |
| 2013 Q4 | 9.12 Million USD | -3.09% |
| 2012 Q4 | 10.44 Million USD | 12.56% |
| 2012 Q1 | 10.94 Million USD | 24.73% |
| 2012 Q2 | 10.24 Million USD | -6.43% |
| 2012 Q3 | 9.27 Million USD | -9.46% |
| 2012 FY | 40.91 Million USD | 19.91% |
| 2011 FY | 34.11 Million USD | -1.06% |
| 2011 Q4 | 8.77 Million USD | 5.16% |
| 2011 Q3 | 8.34 Million USD | 2.2% |
| 2011 Q2 | 8.16 Million USD | -7.47% |
| 2011 Q1 | 8.82 Million USD | -26.53% |
| 2010 Q2 | 7.77 Million USD | 17.29% |
| 2010 FY | 34.48 Million USD | 47.94% |
| 2010 Q4 | 12.01 Million USD | 48.88% |
| 2010 Q3 | 8.06 Million USD | 3.79% |
| 2010 Q1 | 6.62 Million USD | 7.79% |
| 2009 FY | 23.3 Million USD | 8.73% |
| 2009 Q4 | 6.14 Million USD | 6.88% |
| 2009 Q3 | 5.75 Million USD | 3.64% |
| 2009 Q2 | 5.55 Million USD | -5.21% |
| 2009 Q1 | 5.85 Million USD | -26.15% |
| 2008 Q4 | 7.93 Million USD | 84.85% |
| 2008 FY | 21.43 Million USD | 231.91% |
| 2008 Q1 | 5.58 Million USD | 144.87% |
| 2008 Q2 | 5.41 Million USD | -3.03% |
| 2008 Q3 | 4.29 Million USD | -20.73% |
| 2007 Q1 | 1.01 Million USD | -47.21% |
| 2007 Q4 | -12.43 Million USD | -2551.16% |
| 2007 FY | 6.45 Million USD | -68.98% |
| 2007 Q3 | 507.38 Thousand USD | -45.82% |
| 2007 Q2 | 936.46 Thousand USD | -8.02% |
| 2006 Q2 | 2.36 Million USD | 7.54% |
| 2006 Q4 | 1.92 Million USD | -86.55% |
| 2006 FY | 20.82 Million USD | 84955.53% |
| 2006 Q3 | 14.33 Million USD | 506.73% |
| 2006 Q1 | 2.19 Million USD | 0.0% |
| 2005 FY | 24.48 Thousand USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Milestone Scientific Inc. | 13.83 Million USD | -326.539% |
| Retractable Technologies, Inc. | 20.59 Million USD | -186.565% |
| Stereotaxis, Inc. | 36.69 Million USD | -60.825% |